BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Olea Medical Wins FDA 510(k) Clearance for Olea Sphere Medical Imaging Software


7/13/2012 9:06:16 AM

Austin, Texas (PRWEB) July 13, 2012 -- Olea Medical, a Marseilles, France and Boston, Mass.-based medical technology developer, has obtained FDA 510(k) clearance to market its Olea Sphere medical imaging enterprise software package in the US.

Designed to run on Windows, Macintosh and Linux operating systems, Olea Sphere provides display, analysis and post-processing functionality for viewing MRI, CT scan and other medical images, such as perfusion weighted or diffusion weighted images. Using Olea Sphere, medical professionals can not only view but also manipulate and process MRI and CT images. Olea Medical obtained FDA 510(k) clearance with assistance from Austin, Texas-based medical device consultancy Emergo Group.

“It seemed important to us to benefit from the expertise of a specialist in the medical device regulatory field,” Fayçal Djeridane, President and CEO of Olea Medical, explains. “Such an approach usually helps us gain a lot of time with 510(k) file submissions.”

Olea Medical chose to partner with Emergo Group due to the consultancy’s reputation and high level of expertise. “Emergo Group consultants have worked with the FDA on many 510(k) files, so they definitely have the appropriate skills to lead successful submissions,” says Djeridane. “They know exactly the FDA’s expectations and point of view. The result of our investment in teaming with Emergo Group was that we got our 510(k) clearance without delays.”

“The FDA’s 510(k) premarket notification process can be complex and labor-intensive for US-based as well as foreign manufacturers alike,” says Fabio De Pasquale, senior consultant at Emergo Group. “By choosing Emergo Group to provide US FDA registration assistance, Olea Medical was able to bring an innovative medical technology to market in the US quickly and straightforwardly, with no complications.”

About Olea Medical

Olea Medical designs and markets innovative perfusion imaging applications that significantly improve diagnostic processes. Olea Medical aims to become the leader in providing safe and accurate medical imaging software allowing physicians to make faster and improved diagnoses. More information at http://www.olea-medical.com.

About Emergo Group

Emergo Group is a global medical device consulting firm providing a wide range of services for medical device compliance including FDA approval and registration,QMS compliance, clinical trial management, in-country representation, reimbursement and distributor search consulting. Emergo Group can be found online at http://www.emergogroup.com

Additional information:

Caroline Lene

Quality & Regulatory Affairs Manager

Olea Medical

+33.4.42.71.24.22

caroline(dot)lene(at)olea-medical(dot)com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES